Information for ligand P2E
sdf, pdb, mol, mol2
Ligand Name: (z)-7-[(1r,2r,3r)-3-hydroxy-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-cyclopentyl]hept-5-enoic acid
Synonyms
| 1 | Prostaglandin e2 |
| 2 | (5z,13e)-(15s)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate |
| 3 | (5z,13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoate |
| 4 | Dinoprostona |
| 5 | (5z,13e,15s)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid |
| 6 | Pge2 |
| 7 | U-12,062 |
| 8 | Dinoprostone |
| 9 | (15s)-prostaglandin e2 |
| 10 | (e,z)-(1r,2r,3r)-7-(3-hydroxy-2-((3s)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid |
| 11 | Dinoprostonum |
| 12 | Cervidil |
| 13 | Prepidil |
| 14 | Prostin e2 |
| 15 | (5z,11alpha,13e,15s)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid |
| 16 | Propess |
| 17 | Dinoproston |
| 18 | (z)-7-((1r,2r,3r)-3-hydroxy-2-((s,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid |
| 19 | Prostin |
| 20 | Glandin-e2 |
| 21 | Minprositin e2 |
| 22 | U-12062 |
| 23 | Prostarmon e |
| 24 | U 12062 |
| 25 | Minprostin e2 |
| 26 | Cerviprost |
| 27 | Cerviprime |
| 28 | Enzaprost e |
| 29 | Prostenone |
Chemical Component Summary
| Formula | "C20 H32 O5" |
| Molecular Weight | 352.465 |
| SMILES | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CC=C/CCCC(O)=O |
| InchI | InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1 |
| InChIkey | XEYBRNLFEZDVAW-ARSRFYASSA-N |
| DrugBank Reference | DB00917 |
| ChEBI Reference | 15551 |
| PubChem Reference | 5280360 |
| FDA approved drug | yes |
Reference